ArticleFrontiers in oncology2025
An integrated AI-enabled system using One Class Twin Cross Learning for early gastric cancer detection.
Article in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Integrating multiple omics and machine learning to reveal the prognostic value of endoplasmic reticulum stress geneTranslational cancer research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Early detection of gastric cancer, a leading cause of cancer-related mortality worldwide, remains significantly hampered by the limitations of current diagnostic technologies, resulting in high rates of misdiagnosis and missed diagnoses. Methods: To address these clinical challenges, we propose an integrated AI-enabled imaging system that synergizes advanced hardware and software technologies to optimize both speed and diagnostic accuracy. Central to this system is our newly developed One Class Twin Cross Learning (OCT-X) algorithm, which leverages a fast double-threshold grid search strategy (FDT-GS) and a patch-based deep fully convolutional network for precise lesion surveillance and classification in real-time. The hardware platform incorporates an all-in-one point-of-care testing (POCT) device, equipped with high-resolution imaging sensors, real-time data processing capabilities, and wireless connectivity, supported by the NI CompactDAQ system and LabVIEW software for seamless data acquisition and control. Results: This integrated system achieved a diagnostic accuracy of 99.70%, outperforming existing state-of-the-art models by up to 4.47%, and demonstrated a 10% improvement in multirate adaptability, ensuring robust performance across varied imaging conditions and patients profiles. Conclusion: These results highlight the potential of the OCT-X algorithm and the integrated platform to enable more accurate, efficient, and non-invasive early detection of gastric cancer in point-of-care settings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.